BRAF and colorectal carcinoma: On the other hand, BRAF mutations are the most frequent (70–100%) in hypermutated microsatellite instability (MSI)-high (MSI-H) CRC cases that follow the serrated pathway and account for 20–30% of CRC (Figure 1) [6,7,8].